Annual report pursuant to Section 13 and 15(d)

INCOME TAXES (Tables)

v3.24.1
INCOME TAXES (Tables)
12 Months Ended
Dec. 31, 2023
Income Tax Disclosure [Abstract]  
Schedule of components of income tax expense (benefit)
           
    2023     2022  
             
Expected federal income tax benefit at statutory rate   $ 9,464,954     $ 7,184,840  
Non-deductible expenses     1,183,767       (288,249 )
Research and development credit           595,244  
Return to provision true up     108,959       93,285  
Change in valuation allowance     (10,757,680 )     (7,585,120 )
Income tax benefit   $     $  
Schedule of deferred tax assets and liabilities
           
    2023     2022  
Deferred tax assets                
Net operating losses   $ 15,468,757     $ 9,106,430  
Debt basis difference     5,121,397        
Depreciation and amortization     1,701,768       1,502,868  
Research & development credit     1,099,535       1,308,956  
Lease liability     246,704       322,167  
Stock-based compensation     3,235,732       3,103,037  
Inventory     152,749       1,290,968  
Accrued expenses     66,909       233,284  
Capital loss carryover     176,950       261,922  
Dealer rebates     459,713       161,469  
Other     21,828       15,605  
Total     27,752,042       17,306,705  
Valuation allowance     (27,171,016 )     (16,661,612 )
Net deferred tax asset     581,026       645,093  
Deferred tax liabilities                
Prepaid expenses     (342,421 )     (328,836 )
Right-of-use assets     (238,605 )     (316,257 )
Total net deferred taxes Deferred tax liabilities   $     $